Pharmacokinetics and safety of deltoid or gluteal injection of aripiprazole lauroxil NanoCrystal(®) Dispersion used for initiation of the long-acting antipsychotic aripiprazole lauroxil

BACKGROUND: Aripiprazole lauroxil (AL), a long-acting injectable antipsychotic for the treatment of schizophrenia in adults, can be started with either 21 days of daily oral aripiprazole supplementation or a 1-day initiation regimen consisting of a single injection of a NanoCrystal(®) Dispersion for...

Descripción completa

Detalles Bibliográficos
Autores principales: Hard, Marjie L., Wehr, Angela, von Moltke, Lisa, Du, Yangchun, Farwick, Sarah, Walling, David P., Sonnenberg, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607563/
https://www.ncbi.nlm.nih.gov/pubmed/31308935
http://dx.doi.org/10.1177/2045125319859964

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607563/
https://www.ncbi.nlm.nih.gov/pubmed/31308935
http://dx.doi.org/10.1177/2045125319859964

Ejemplares similares